Critical roles for the serine 20, but not the serine 15, phosphorylation site and for the polyproline domain in regulating p53 turnover

被引:57
|
作者
Dumaz, N [1 ]
Milne, DM [1 ]
Jardine, LJ [1 ]
Meek, DW [1 ]
机构
[1] Univ Dundee, Ninewells Hosp & Med Sch, Ctr Biomed Res, Dundee DD1 9SY, Scotland
关键词
DNA damage; tumour suppressor; ubiquitination;
D O I
10.1042/0264-6021:3590459
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The p53 tumour suppressor protein is a short-lived transcription factor that becomes stabilized in response to a wide range of cellular stresses. Ubiquitination and the targeting of p53 for degradation by the proteasome are mediated by Mdm2 (mouse double minute clone 2), a negative regulatory partner of p53. Previous studies have suggested that DNA-damage-induced phosphorylation of p53 at key N-terminal sites has a pivotal role in regulating the interaction with Mdm2 but the precise role of phosphorylation of serines 15 and 20 is still unclear. Here we show that replacement of serine 15 and a range of other key N-terminal phosphorylation sites with alanine, which cannot be phosphorylated, has little effect on the ubiquitination and degradation of full-length human p53. In contrast, replacement of serine 20 makes p53 highly sensitive to Mdm2-mediated turnover. These results define distinct roles for serines 15 and 20, two sites previously demonstrated to be dependent on phosphorylation through mechanisms mediated by DNA damage and ATM (ataxia telangiectasia mutated). We also show that the polyproline region of p53, a domain that has a key role in p53-induced apoptosis, exerts a critical influence over the Mdm2-mediated turnover of p53.
引用
收藏
页码:459 / 464
页数:6
相关论文
共 50 条
  • [31] Serine 312 phosphorylation is dispensable for wild-type p53 functions in vivo
    Lee, M. K.
    Tong, W. M.
    Wang, Z. Q.
    Sabapathy, K.
    CELL DEATH AND DIFFERENTIATION, 2011, 18 (02): : 214 - 221
  • [32] Serine 312 phosphorylation is dispensable for wild-type p53 functions in vivo
    M K Lee
    W M Tong
    Z Q Wang
    K Sabapathy
    Cell Death & Differentiation, 2011, 18 : 214 - 221
  • [33] Defect in serine 46 phosphorylation of p53 contributes to acquisition of p53 resistance in oral squamous cell carcinoma cells
    Ichwan, SJA
    Yamada, S
    Sumrejkanchanakij, P
    Ibrahim-Auerkari, E
    Eto, K
    Ikeda, MA
    ONCOGENE, 2006, 25 (08) : 1216 - 1224
  • [34] Phosphorylation,of p53 at serine 15 in A549 pulmonary epithelial cells exposed to vanadate: Involvement of ATM pathway
    Suzuki, Katsura
    Inageda, Kiyoshi
    Nishitai, Gen
    Matsuoka, Masato
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2007, 220 (01) : 83 - 91
  • [35] Expression of p53 protein phosphorylated at serine 20, serine 392 and apoptosis-related proteins in ovarian carcinomas
    Bar, J.
    Slomska, I.
    Noga, L.
    Rabczynski, J.
    Grybos, M.
    Jelen, M.
    VIRCHOWS ARCHIV, 2010, 457 (02) : 218 - 219
  • [36] Serine15 phosphorylation stimulates p53 transactivation but does not directly influence interaction with HDM2
    Dumaz, N
    Meek, DW
    EMBO JOURNAL, 1999, 18 (24): : 7002 - 7010
  • [37] Defect in serine 46 phosphorylation of p53 contributes to acquisition of p53 resistance in oral squamous cell carcinoma cells
    S J A Ichwan
    S Yamada
    P Sumrejkanchanakij
    E Ibrahim-Auerkari
    K Eto
    M-A Ikeda
    Oncogene, 2006, 25 : 1216 - 1224
  • [38] Induction of p53 Phosphorylation at Serine 20 by Resveratrol Is Required to Activate p53 Target Genes, Restoring Apoptosis in MCF-7 Cells Resistant to Cisplatin
    Hernandez-Valencia, Jorge
    Garcia-Villa, Enrique
    Arenas-Hernandez, Aquetzalli
    Garcia-Mena, Jaime
    Diaz-Chavez, Jose
    Gariglio, Patricio
    NUTRIENTS, 2018, 10 (09)
  • [39] Differences in the association of p53 phosphorylated on serine 15 and key enzymes of homologous recombination
    Anja Restle
    Christine Janz
    Lisa Wiesmüller
    Oncogene, 2005, 24 : 4380 - 4387
  • [40] Differences in the association of p53 phosphorylated on serine 15 and key enzymes of homologous recombination
    Restle, A
    Janz, C
    Wiesmüller, L
    ONCOGENE, 2005, 24 (27) : 4380 - 4387